A drug developed by Armenian scientists looks like justifying hopes pinned on it. 300 patient have so far been treated with it at Yerevan’s Armenicum clinic. “All those treated are still alive and none of them have had complaints over the period of clinical tests,” David Aslanyan, Armenicum’s spokesman is quoted as saying. One course of treatment is a week-long, and each patient is supposed to take 3 such courses. The cost of treatment is estimated at about $1,000. According to RIA Novosti, the Armenicum medical centre, located in the Republic of Armenia’s capital city, is operating mainly thanks to private investments. At present, negotiations are being held with countries willing to register the drug. The centre’s officials say the medical business transnationals try to block the advancement of the drug - $600bn is spent annually on the treatment of AIDS patients.
As November 4 approaches (on this day, Russia and Belarus are to sign union programs), disputes between supporters and opponents of the integration become increasingly heated